Gastric cancer is more common in East Asia than other areas, but its epidemic trends and therapeutic mode is distinctive in China. As the standard surgery has been implemented in most medical centers in China, it is the responsivities of Chinese young surgeons to improve the care of gastric cancer and scientific evaluation of different treatment strategies with well-designed clinical trial. Japan and Korea have initiated and accomplished many clinical trials, and these results have been adopted in daily treatment,and broaden their academic influences. Young surgeons from Korea has been nominated as principal investigators for newest clinical trial in Korea and participant enrollment has been finished as scheduled. Young surgeons should broad vision and improve quality, and with the context of clinical trials,collaborate intensively with colleagues from Korea and Japan,and deliver the optimal treatment for patients.